Skip to content

Clarity Pharmaceuticals – Radiopharmaceutical Therapies and Imaging

Clarity is a clinical stage radiopharmaceutical company developing next-generation products to improve treatment outcomes for children and adults with cancer

Home
Company
Pipeline
Technology
News
Investor Centre
LinkedIn
Twitter

Home
Company
Pipeline
Technology
News
Investor Centre
LinkedIn
Twitter

Reports and Presentations

Corporate Governance
Financial reports
ASX releases
Shareholder meetings
Analyst Coverage
Shareholder updates
Share Registry

Presentations

AGM Presentation Thumbnail

Presentation Thumbnail

Presentation Thumbnail

Presentation Thumbnail3

E&P Presentation thumbnail2

Presentation Thumbnail

Annual Reports

Website thumbnail

AR Thumbnail

Artboard 1

Half-Yearly Reports

HY thumbnail website

website

Quarterly Reports

Website thumbnail

Website thumbnail

Website thumbnail

Quarterly thumbnail

23-10-31 Qly Thumbnail

Website Thumbnail

23-04-28 Qly Thumbnail

Corporate Governance Statement

Corp Govern cover

4G cover thumbnail

Corpotate governance statement 22

ESG Report

Thumbnail

ESG thumbnail small

Prospectus

Prospectus Thumbnail

Newsletter

Sign up to receive Clarity's most recent news and updates

4 Cornwallis Street,
National Innovation Centre,
Eveleigh 2015 NSW
+61 (0)2 9209 4037

Board of Directors

Scientific Advisors

About SAR-Technology

Copper Isotopes

Intellectual Property

Investor Center

bd@claritypharmaceuticals.com

SUBSCRIBE TO CLARITY’S NEWSLETTER

Sign up to receive the most recent news and updates.

© Clarity Pharmaceuticals 2022 Australia